Filtros de búsqueda

Lista de obras de

A case of fulminant hepatic failure caused by hepatitis E virus

artículo científico publicado en 2008

A case of syndrome of inappropriate secretion of antidiuretic hormone following transarterial embolization with cisplatin

artículo científico publicado en 2014

A first case of hepatic angiosarcoma treated with recombinant interleukin-2.

artículo científico publicado en 2011

A second attack of cholestasis associated with erythropoietic protoporphyria was successfully treated by plasma exchange and blood transfusion

scientific article published on 10 June 2014

Achievement of sustained viral response after switching treatment from pegylated interferon α-2b to α-2a and ribavirin in patients with recurrence of hepatitis C virus genotype 1 infection after liver transplantation: a case report.

artículo científico publicado en 2011

Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C

artículo científico publicado en 2018

Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy

artículo científico publicado en 2010

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection

artículo científico publicado en 2016

Assessment of Outcome of Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma by the Combination of RECIST and Tumor Markers

Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A.

artículo científico publicado en 2015

Balloon-occluded retrograde transvenous obliteration for portal-systemic encephalopathy due to superior mesenteric-caval shunt via the right gonadal vein

artículo científico publicado en 2007

Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage

artículo científico publicado en 2002

CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients

article

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.

artículo científico publicado en 2018

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

artículo científico publicado en 2012

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy

artículo científico publicado en 2011

Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid

artículo científico publicado en 2016

Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib

artículo científico publicado en 2014

Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombus

scientific article published on 01 November 2011

Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice

artículo científico publicado en 2018

Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma

artículo científico publicado en 2017

Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma

artículo científico publicado en 2008

Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma

artículo científico publicado en 2002

Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases

artículo científico publicado en 2008

Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy.

artículo científico publicado en 2011

Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis

artículo científico publicado en 2018

Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization

artículo científico publicado en 2016

Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status

artículo científico publicado en 2018

Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma

artículo científico publicado en 2018

Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2015

Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases

artículo científico publicado en 2016

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study

scientific article published on 01 January 2019

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

artículo científico publicado en 2017

Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

artículo científico publicado en 2015

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

artículo científico publicado en 2014

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.

artículo científico publicado en 2015

Differences in serum microRNA profiles in hepatitis B and C virus infection.

artículo científico publicado en 2014

Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trial

artículo científico publicado en 2008

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

artículo científico publicado en 2012

Early experience of seven hepatocellular carcinoma cases treated with regorafenib

scientific article published on 11 October 2018

Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis

artículo científico publicado en 2015

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.

artículo científico publicado en 2016

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma

artículo científico publicado en 2007

Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.

artículo científico publicado en 2016

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

artículo científico publicado en 2017

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.

artículo científico publicado en 2017

Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study

artículo científico publicado en 2017

Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus

artículo científico publicado en 2014

Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis

artículo científico publicado en 2014

Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma

artículo científico publicado en 2007

Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases

artículo científico publicado en 2015

Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled t

artículo científico publicado en 2007

Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.

artículo científico publicado en 2017

Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes

artículo científico publicado en 2018

Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining

artículo científico publicado en 2011

Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

artículo científico publicado en 2018

Erratum: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer

artículo científico publicado en 2016

Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center

artículo científico publicado en 2008

Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers

scientific article published on 01 April 2015

Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring

artículo científico publicado en 2018

Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices

artículo científico publicado en 2009

FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma

scientific article published on 01 February 2009

Genomic Characterization of Biliary Tract Cancers Identifies Driver Genes and Predisposing Mutations.

artículo científico publicado en 2018

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients

artículo científico publicado en 2017

HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study

artículo científico publicado en 2013

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.

artículo científico publicado en 2018

Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle

artículo científico publicado en 2012

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms

artículo científico publicado en 2015

IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2016

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

artículo científico publicado en 2011

ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C.

artículo científico publicado en 2016

Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping

artículo científico publicado en 2004

Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib

artículo científico publicado en 2017

Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

artículo científico publicado en 2010

Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.

artículo científico publicado en 2015

In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors

artículo científico publicado en 2018

Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus.

artículo científico publicado en 2015

Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers

artículo científico publicado en 2014

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

artículo científico publicado en 2014

Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation

artículo científico publicado en 2012

Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis

artículo científico publicado en 2009

Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases

artículo científico publicado en 2010

Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

artículo científico publicado en 2017

Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia

artículo científico publicado en 2017

Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection

artículo científico publicado en 2016

Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy

artículo científico publicado en 2015

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies

artículo científico publicado en 2015

Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration

artículo científico publicado en 2014

Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma

artículo científico publicado en 2007

Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease

artículo científico publicado en 2014

Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients

artículo científico publicado en 2013

Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients

artículo científico publicado en 2013

Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastases.

artículo científico publicado en 2010

Predicting the response to 48-week combination therapy with peginterferon alpha-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patients

artículo científico publicado en 2009

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

artículo científico publicado en 2013

Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma

artículo científico publicado en 2016

Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus

artículo científico publicado en 2010

Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy

scientific article published on 01 April 2008

Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients

artículo científico publicado en 2015

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

artículo científico publicado en 2009

Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients

artículo científico publicado en 2016

Recent trend of clinical features in patients with hepatocellular carcinoma

artículo científico publicado en 2011

Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study

artículo científico publicado en 2018

Response to "treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for 'middle'?"

artículo científico publicado en 2013

Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis

artículo científico publicado en 2017

Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis

artículo científico publicado en 2012

Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

artículo científico publicado en 2014

Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.

artículo científico publicado en 2016

Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine

artículo científico publicado en 2007

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

artículo científico publicado en 2017

Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma

artículo científico publicado en 2007

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

scientific article published on 20 July 2018

Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient

artículo científico publicado en 2008

Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation

artículo científico publicado en 2014

Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT.

artículo científico publicado en 2013

The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients

artículo científico publicado en 2017

The first Japanese case of COACH syndrome

artículo científico publicado en 2009

The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma; comparison with interferon-based therapy

scientific article published on 19 November 2018

The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration

artículo científico publicado en 2007

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients

artículo científico publicado en 2016

The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease

artículo científico publicado en 2016

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

artículo científico publicado en 2017

Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report

artículo científico publicado en 2015

Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation

artículo científico publicado en 2017

Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines

artículo científico publicado en 2012

Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation.

artículo científico publicado en 2014

Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy

artículo científico publicado en 2009

Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma

artículo científico publicado en 2015

Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

scientific article published on 02 April 2013

Vitamin D supplementation on IFN-based therapy

artículo científico publicado en 2015

Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors

artículo científico publicado en 2016

Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

artículo científico publicado en 2016

Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity

artículo científico publicado en 2015

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

artículo científico publicado en 2012

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury

artículo científico publicado en 2017

Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma

artículo científico publicado en 2010

[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP]

artículo científico publicado en 2012

[A case of clonorchiasis complicated with the expansion of liver cyst]

artículo científico publicado en 2013

[Case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment]

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda